Clinical trials referenced in this document:
Documents that mention this clinical trial
Effect of low-dose tadalafil once daily on glycemic control in patients with type 2 diabetes and erectile dysfunction: a randomized, double-blind, placebo-controlled pilot study
Received: 17 November 2021
Accepted: 3 April 2022
First Online: 21 April 2022
: The present study protocol was reviewed and approved by the institutional review board of Myongji hospital (approval no. MJH-16-038). The study was conducted following the protocol, the ethical principles stated in the Declaration of Helsinki (revised in 2000), and the applicable laws.
: The written informed consents for publication were acquired from each participant.
: The authors declare there are no competing interests.